HOME >Rice Kefiran・TOP >Suppression of blood pressure elevation and anti-arteriosclerosis action
   Suppression of blood pressure elevation and anti-arteriosclerosis action

We investigated the effects on the suppression of blood pressure elevation and anti-arteriosclerosis action by the administration of refined Rice Kefiran for 30 days in stroke-prone spontaneously hypertensive rats (six-week-old male SHRSP/Hos rats) feeding on high-fat diet. In blood pressure recordings on the baseline, 15th, and 30th days, the administered group showed significantly lower values than the control group. In the measurement of total lipids, total cholesterol, and triglyceride, the administered group also showed significantly lower values than the control group. In the histopathological examination of the brain, the large artery, and the coronary artery for the control group, lipid deposition was detected in the basilar artery and the endomembrane of the aortic arch, adhesion of the intramural thrombi was observed in the aortic arch, and fibrin thrombi were observed in the intracoronary artery. The refined Rice Kefiran group showed lower-grade lesions than the control group and the lipid deposition in the endomembrane of the aortic arch was also detected at the low-grade. Consequently, it was suggested that Rice Kefiran showed suppression of blood pressure elevation and anti-arteriosclerosis action.

■Effect of refined Rice Kefiran on blood pressure and serum ACE activity in
  SHRSP/Hos rats
                         Control group       Refined Rice Kefiran       Refined Rice Kefiran
                          (n=10)          100mg/kggroup          300mg/kggroup
                                          (n=10)               (n=10)
Systolic blood pressure (mmHg)
Baseline              163.5± 3.4      169.8± 5.2       156.6± 2.4
15th day              186.5± 6.4      179.7± 2.4       168.6± 4.5a,b
30th day              192.1± 3.0      181.9± 4.6aa      173.1± 4.0aa,b
Diastolic blood pressure (mmHg)
Baseline              124.2± 4.2      122.1± 2.3       136.4± 6.8
15th day              139.2± 5.5      139.8± 2.4       136.5± 2.3
30th day              158.9± 4.0      147.8± 3.4a       135.2± 3.9aa,bb
ACE activity (U/I)         21.73± 0.29     20.28± 0.43aa      19.80± 0.60a
Mean ± standard deviation. A significant difference to the control group: a, p < 0.05; aa, p < 0.01;
a significant difference to the refined Rice Kefiran 100mg/kg group: b, p < 0.05; bb, p < 0.01.

■Effect of refined Rice Kefiran on serum lipid in SHRSP/Hos rats
  Control group
   (n=10)
  Refined Rice Kefiran
   100mg/kggroup
    (n=10)
  Refined Rice Kefiran
   300mg/kggroup
    (n=10)
Total lipids
(mg/dL)
  973.00±27.01   964.20±30.49   897.40±18.40a
Total cholesterol (mg/dL)   495.60±13.57   475.80±16.77   450.30±12.29aa
VLDL-cholesterol (mg/dL)   174.03± 5.61   152.25± 5.37a   150.52± 4.63aa
LDL-cholesterol (mg/dL)   310.79± 9.57   294.99±10.40   272.77± 8.79aa
HDL-cholesterol (mg/dL)   24.30± 0.75   23.81± 0.84   23.54± 0.76
Triglyceride
(mg/dL)
  46.30± 2.67   41.40± 4.17   28.40± 2.98aa,b
VLDL-triglyceride (mg/dL)   43.38± 3.28   34.38± 3.46   18.36± 1.78aa,bb
LDL-triglyceride (mg/dL)   4.56± 0.46   3.43± 0.24a   2.70± 0.46aa
HDL-triglyceride (mg/dL)   2.38± 0.13   2.31± 0.15   2.30± 0.17
Mean ± standard deviation. A significant difference to the control group: a, p < 0.05; aa, p < 0.01;
a significant difference to the refined Rice Kefiran 100mg/kg group: b, p < 0.05; bb, p < 0.01.


Copyright(C)2007 JAFRA. All rights reserved.